-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Crinetics Pharmaceuticals (CRNX) Stock Up 64% Today?
Crinetics Pharmaceuticals (CRNX) stock is on the rise Monday after the company announced positive clinical trial results.
Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?
Impel Pharmaceuticals (IMPL) stock is on the rise Friday after the company announced an amended agreement with Oaktree Fund Administration.
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.
Why Is Palisade Bio (PALI) Stock Down 46% Today?
Palisade Bio (PALI) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering.
Why Is NeuBase Therapeutics (NBSE) Stock Down 27% Today?
NeuBase Therapeutics (NBSE) stock is dropping on Thursday but that's only due to the company coming off a massive rally yesterday.
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?
China SXT Pharmaceuticals (SXTC) stock is heading higher on Thursday even without any news from the pharmaceutical company.
Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?
NeuBase Therapeutics (NBSE) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company.